Antisense oligonucleotides with different backbones - Modification of splicing pathways and efficacy of uptake

被引:81
|
作者
Schmajuk, G
Sierakowska, H
Kole, R
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.274.31.21783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel, positive read-out assay that quantifies only sequence-specific nuclear activity of antisense oligonucleotides was used to evaluate morpholino and 2'-O-methyl sugar-phosphate oligonucleotides. The assay is based on modification of the splicing pathway of human beta-globin pre-mRNA, In addition, scrape-loading of cells with oligonucleotides allows the separate assessment of intracellular antisense activity of the oligonucleotides and their ability to penetrate the cell membrane barrier. The results show that, with scrape-loading, the morpholino oligonucleotides were approximately 3-fold more effective in their intrinsic antisense activity than alternating phosphodiester/phosphorothioate 2'-O-methyl-oligoribonucleotides and 6-9- and almost 200-fold more effective than the exclusively phosphorothioate and phosphodiester derivatives, respectively. The morpholino oligonucleotides were over 20-fold more effective than the phosphorothioate 2'-O-methyl-oligoribonucleotides in free uptake from the culture media. The antisense activity of the morpholino oligonucleotides was detectable not only in monolayer HeLa cells but also in suspension K562 cells. Time course experiments suggest that both the free uptake and efflux of morpholino oligonucleotides are slow.
引用
收藏
页码:21783 / 21789
页数:7
相关论文
共 50 条
  • [31] Bioavailability of antisense oligonucleotides in neuroblastoma cells: Comparison of efficacy among different types of molecules
    Corrias, MV
    Guarnaccia, F
    Ponzoni, M
    JOURNAL OF NEURO-ONCOLOGY, 1997, 31 (1-2) : 171 - 180
  • [32] Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules
    Maria Valeria Corrias
    Francesco Guarnaccia
    Mirco Ponzoni
    Journal of Neuro-Oncology, 1997, 31 : 171 - 180
  • [33] ANTISENSE OLIGONUCLEOTIDES AS SPLICING MODULATORS IN ORGANOIDS - NOVEL INSIGHTS INTO A POTENTIAL THERAPY
    Stanleigh, N.
    Sinai, Irony-Tur M.
    Wilschanski, M.
    Kerem, E.
    Kerem, B.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S320 - S320
  • [34] Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa
    Hainzl, Stefan
    Trattner, Lisa
    Liemberger, Bernadette
    Bischof, Johannes
    Kocher, Thomas
    Ablinger, Michael
    Nystroem, Alexander
    Obermayer, Astrid
    Klausegger, Alfred
    Guttmann-Gruber, Christina
    Wally, Verena
    Bauer, Johann W.
    Hofbauer, Josefina Pinon
    Koller, Ulrich
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [35] IDENTIFICATION AND CHARACTERIZATION BY ANTISENSE OLIGONUCLEOTIDES OF EXON AND INTRON SEQUENCES REQUIRED FOR SPLICING
    DOMINSKI, Z
    KOLE, R
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (11) : 7445 - 7454
  • [36] Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
    Anderson, Brooke A.
    Freestone, Graeme C.
    Low, Audrey
    De-Hoyos, Cheryl L.
    Drury, William J., III
    Ostergaard, Michael E.
    Migawa, Michael T.
    Fazio, Michael
    Wan, W. Brad
    Berdeja, Andres
    Scandalis, Eli
    Burel, Sebastien A.
    Vickers, Timothy A.
    Crooke, Stanley T.
    Swayze, Eric E.
    Liang, Xuehai
    Seth, Punit P.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (16) : 9026 - 9041
  • [37] Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides
    White, Paul J.
    Anastasopoulos, Frank
    Pouton, Colin W.
    Boyd, Ben J.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [38] Increased uptake of antisense oligonucleotides by delivery as double stranded complexes
    Astriab-Fisher, A
    Fisher, MH
    Juliano, R
    Herdewijn, P
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (03) : 403 - 407
  • [39] MODIFIED OLIGONUCLEOTIDES IN RABBIT RETICULOCYTES - UPTAKE, STABILITY AND ANTISENSE PROPERTIES
    BOIZIAU, C
    TOULME, JJ
    BIOCHIMIE, 1991, 73 (11) : 1403 - 1408
  • [40] Comparison of the exon skipping efficacy of different chemically modified antisense oligonucleotides within the mouse retina
    Vazquez-Dominguez, I.
    Allo-Anido, A.
    Duijkers, L.
    Hoppenbrouwers, T.
    Hoogendoorn, A.
    Collin, R. W. J.
    Garanto, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A132 - A132